Mozobil for Autologous Hematopoietic Stem Cell Transplantation

NCT07188090 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Hodgkin Lymphoma
Non-hodgkin Lymphoma

Interventions

DRUG: Plerixafor
DRUG: Gcsf

Sponsor

Thomas Jefferson University